Bat Exposure Prophylaxis Protocol
For individuals exposed to bats, the recommended post-exposure prophylaxis regimen consists of wound cleansing, human rabies immune globulin (HRIG), and a 4-dose rabies vaccine series administered on days 0,3,7, and 14. 1
Assessment of Bat Exposures
Bat exposures require special consideration due to the high risk of rabies transmission:
Indications for prophylaxis:
No prophylaxis needed if:
- The bat is captured and tests negative for rabies
- Person was awake and certain no bite or mucous membrane exposure occurred 2
Post-Exposure Prophylaxis Protocol
1. Wound Management
- Immediately and thoroughly cleanse all wounds with soap and water 3
- Irrigate with virucidal agent such as povidone-iodine solution if available 1
- This local wound cleansing significantly reduces rabies transmission risk
2. For Previously Unvaccinated Individuals:
Human Rabies Immune Globulin (HRIG):
Rabies Vaccine:
3. For Previously Vaccinated Individuals:
- No HRIG needed 1
- Rabies Vaccine:
- Two 1.0 mL doses of HDCV or PCECV administered intramuscularly in deltoid
- Schedule: Days 0 and 3 only 1
Timing Considerations
- Begin prophylaxis immediately after exposure 2
- No absolute time limit for initiating PEP - should be given regardless of delay 2
- If bat can be captured, submit for testing - but do not delay PEP if testing will take time 2
Common Pitfalls to Avoid
Inappropriate administration sites: Vaccine must be administered in the deltoid area in adults and older children (never in gluteal area) 1
Inadequate wound infiltration: Failure to properly infiltrate HRIG around wounds increases risk of treatment failure 1
Delaying treatment: Substantial delays between exposure and prophylaxis increase risk, especially with head/face wounds 1
Underestimating bat exposures: Minor bat bites can go undetected but still transmit rabies 3
Waiting for animal testing: Do not delay PEP while waiting for bat testing if significant delay is expected 2
Effectiveness and Safety
- PEP is nearly 100% effective when administered properly according to guidelines 2
- Local reactions (pain, erythema at injection site) occur in up to 74% of recipients 1
- Mild systemic reactions (headache, nausea) occur in 5-40% of recipients 1
- Systemic allergic reactions are rare (approximately 11 per 10,000 vaccinees) 1
The 4-dose vaccine regimen (replacing the previous 5-dose regimen) has been shown to be equally effective while reducing healthcare costs and patient burden 1.